Core Insights - Kimberly-Clark Corporation (NASDAQ:KMB) is viewed as potentially bottoming out, with a turnaround in progress as noted by Jim Cramer [1] - The company is recognized for its personal care and tissue products, including baby care, feminine care, incontinence, and household paper products [1] - CEO Michael Hsu is leading a restructuring effort that is currently underappreciated in the market [1] Company Overview - Kimberly-Clark manufactures and sells a variety of personal care and tissue products [1] - The company is described as being in the midst of a "terrific turnaround" [1] Market Position - Cramer highlights Kimberly-Clark as a company with a 4% yield, indicating its attractiveness for income-focused investors [1] - The company is compared to Procter & Gamble, which has already begun a similar turnaround process [1] Investment Perspective - While Kimberly-Clark shows potential, there are suggestions that certain AI stocks may offer greater upside potential and less downside risk [1]

Investment Thesis - Analyst's best investment idea is Kimberly Clark due to a lack of appealing alternatives in cash, bonds, and high-performing stocks [1] - Kimberly Clark is favored as a defensive play in the fourth quarter, with stocks still preferred over bonds and cash [3] - The company's products exhibit economic insensitivity, making it a safe haven during economic uncertainty [2][10] Company Performance & Valuation - Kimberly Clark's stock is down 20% over the last 52 weeks and 9% year-to-date [2] - The stock trades at approximately 165 times earnings and offers a 42% dividend yield [2] Competitive Landscape - While the utility sector is also defensive and offers dividends, Kimberly Clark is currently preferred [4][5] - Within the utility sector, divergence exists due to the data center boom, requiring careful stock selection; Dominion and Clearway Energy are liked, but Kimberly Clark is favored more [6][7] - Kimberly Clark is preferred over Clorox due to lower economic sensitivity in its product purchases; consumers are less likely to switch to generic brands within the Kimberly Clark family [9][10][11] Risks & Considerations - Tariffs are increasing costs, but the analyst is not worried about Kimberly Clark's pricing power, as many products are made domestically [8][9]

So, it's way less bullish than the previous three. So, my best idea is Kimberly Clark. And the reason I like it is because I don't like anything else. I don't like cash. I don't like bonds.I don't like areas of the market that have done well. I don't like stocks that are already up 25 or 50%. So, what you've got with Kimberly, which by the way, we all know what Kimberly does.They make Kleenex, Huggies, toilet paper, they make Scots toilet paper, and then the, you know, higherend Cottonell toilet paper. Um, ...

Core Viewpoint - Kimberly-Clark Corporation (NASDAQ:KMB) is recognized as a low PE high dividend stock, with analysts highlighting its strong dividend history and energy exposure as key factors for consideration [1][4]. Group 1: Financial Performance and Valuation - Jefferies initiated coverage of Kimberly-Clark with a Hold rating and a price target of $130, noting a tripling of its natural gas backlog since 2023 and significant exposure to LNG and Southeast power demand [2]. - The stock is currently trading at approximately 10.5 times its projected FY2028 EV/EBITDA, which is higher than the industry average of around 9 times, indicating that much of the positive outlook is already reflected in its valuation [3]. Group 2: Dividend Appeal - Kimberly-Clark has a strong dividend track record, having increased its dividend for 52 consecutive years, with a current yield of 4.19% and a quarterly dividend payment of $1.26 per share [4]. Group 3: Company Overview - Kimberly-Clark is a global consumer goods company known for its disposable products, including diapers, tissues, and paper towels, with its brands available in over 175 countries through various retail channels [5].

Core Insights - Kimberly-Clark Corporation (NASDAQ:KMB) is recognized as a top growth stock for long-term investors [1] - The company operates globally, selling disposable consumer goods in 175 countries, with revenue primarily from well-known brands [2] Group 1: Growth Strategy - A significant focus for future growth is on expanding in developing and emerging markets, which already contribute a substantial share of total sales [3] - The company aims to enhance its personal care and professional segments in regions with low product usage and market penetration [3] - Cost-saving initiatives and share repurchase programs are being implemented, contributing to higher earnings per share [3] Group 2: Financial Performance and Dividends - Kimberly-Clark benefits from steady demand for its products, making it a reliable choice for income-focused and risk-averse investors [4] - The company achieved its 53rd consecutive annual dividend increase, positioning it as a strong dividend aristocrat [4] - It offers a quarterly dividend of $1.26 per share, with a dividend yield of 4.22% as of October 12 [4]

Core Viewpoint - Sarasin & Partners LLP has significantly increased its stake in Kimberly-Clark by acquiring 963,978 shares valued at approximately $119.87 million, raising its total holdings to 2,048,544 shares worth $251.27 million as of September 30, 2025 [1][2]. Company Overview - Kimberly-Clark reported a total revenue of $18.88 billion and a net income of $2.43 billion for the trailing twelve months (TTM) [4]. - The company offers a dividend yield of 4.22% as of October 9, 2025, with its stock priced at $119.55 [4]. Business Model - Kimberly-Clark manufactures and markets personal care products, consumer tissue, and professional hygiene solutions under well-known brands such as Huggies, Kleenex, Scott, and Kotex [5]. - The company generates revenue primarily through the sale of branded disposable consumer products, utilizing a global distribution network that includes supermarkets, mass merchandisers, and e-commerce channels [5]. Market Position - Kimberly-Clark is recognized as a leading global provider of personal care and tissue products, serving a diverse customer base that includes individual consumers, retail outlets, and commercial institutions across various sectors [6]. - The company has maintained a diversified portfolio of established brands, which supports its market presence [6]. Investment Insights - Despite a decline in stock price, down 15.9% over the year ending October 9, 2025, Kimberly-Clark's dividend history is notable, having increased dividends for over 50 years, making it a reliable choice for income-focused investors [3][9]. - The KMB position now constitutes 2.47% of Sarasin & Partners LLP's 13F reportable assets under management (AUM) as of September 30, 2025 [3].

Core Insights - Kimberly-Clark Corporation (KMB) is enhancing its market position through innovation, a consumer-centric approach, and strategic investments in product development [1][2] - The company's Powering Care strategy focuses on accelerating growth, operational efficiency, and organizational alignment [1][2] Strategy and Innovation - The Powering Care strategy prioritizes accelerating innovation, optimizing margin structure, and restructuring for growth, which strengthens KMB's global category leadership [2][10] - Management's commitment to delivering unique, higher-value products is expected to drive premiumization and cater to evolving consumer demands, enhancing brand strength [3][5] - Innovation remains central to KMB's strategy, with new product launches like Skin Essentials appealing to both premium and value-conscious segments [4][10] Financial Performance and Estimates - KMB's shares have declined by 8.7% year-to-date, compared to a 10% drop in the industry [8] - The forward price-to-earnings ratio for KMB is 16.76X, lower than the industry average of 18.73X [9] - The Zacks Consensus Estimate for KMB's 2025 earnings per share (EPS) indicates a year-over-year decline of 11.1%, while 2026 shows growth of 12.4% [11]

Core Insights - Kimberly-Clark Corporation is enhancing its commitment to women's and girls' essential care through four strategic partnerships, aiming to improve the lives of an estimated 24 million women and girls over the next three years [1][9][10] - The Kimberly-Clark Foundation is funding a three-year commitment of $28.7 million focused on menstrual care and maternal & infant care [2][4][10] Partnership Initiatives - The partnerships include collaborations with Baby2Baby, Plan International, Project HOPE, and UNICEF, targeting countries such as Brazil, Peru, China, India, Indonesia, Vietnam, and the United States [1][9] - Baby2Baby will receive support to address rising maternal mortality rates in the U.S. through the distribution of Maternal Health & Newborn Supply Kits [5][6] - Plan International has reached over 11 million people since 2020, focusing on menstrual health and creating supportive environments for girls [6][7] Health and Education Focus - The programs will include menstrual hygiene education, maternal mental health support, and comprehensive perinatal and newborn care services [4][10] - Project HOPE will expand access to menstrual and maternal health education in China and Indonesia, emphasizing a life-cycle approach [7][8] Long-term Vision - Kimberly-Clark aims to positively impact 1 billion lives by 2030, aligning its initiatives with its Powering Care business strategy [11][12] - The integrated approach of these partnerships reflects the interconnected challenges of menstrual health, maternal wellbeing, and infant development [10][11]

Core Thesis - Kimberly-Clark Corporation (KMB) is viewed positively due to its strong cash flows, consistent dividend increases, and essential consumer products, making it an attractive investment for long-term, dividend-focused investors [1][4]. Company Overview - Kimberly-Clark is a global leader in consumer essentials, known for brands like Kleenex, Huggies, Scott, and Cottonelle, with products sold in over 175 countries [2]. - The company has a history of resilience and stability in consumer demand, which remains consistent across economic cycles [2]. Financial Performance - KMB has achieved 52 consecutive years of dividend increases, earning the title of Dividend King, with a current dividend yield of approximately 3.6% and a five-year growth rate averaging 3-4% annually [3]. - The company has also engaged in significant share buybacks, enhancing its appeal to long-term investors [3]. Investment Appeal - KMB offers a reliable, cash-generating business model that is not high-growth but rewards patient, long-term investment [4]. - The combination of steady revenue streams, strong brand loyalty, and disciplined capital allocation positions Kimberly-Clark as a blueprint for resilient, long-term value creation [4].

Core Insights - Kimberly-Clark Corporation is a multinational company specializing in hygiene and personal care products, with a market capitalization of $39.99 billion and operations in over 175 countries [1] Financial Performance - The company is expected to report a 10.9% year-over-year decline in profit to $1.63 per diluted share for Q3 fiscal 2025 [2] - For the fiscal year 2025, analysts predict an 11% decrease in profit to $6.50 per diluted share compared to the previous year [3] Stock Performance - Kimberly-Clark's stock has underperformed the broader market, losing 13.1% over the past 52 weeks and 6.7% year-to-date, while the S&P 500 Index has gained 17.9% and 14.2% respectively [4] - The company has also underperformed the Consumer Staples Select Sector SPDR Fund (XLP), which has dropped 3.1% over the past 52 weeks [5] Recent Results - In Q2, Kimberly-Clark reported net sales of $4.16 billion, a 1.6% year-over-year decrease, impacted by a 4.4% adverse effect from divestitures and business exits [6] - The adjusted EPS for Q2 was $1.92, down 2% year-over-year but exceeding analyst expectations of $1.68, leading to a 4.8% intraday stock rise on the reporting day [6]